CANSLIM Stocks
Developed by William O'Neil of Investor's Business Daily, CANSLIM is a method of screening for stocks based on the folllowing seven characteristics. It should be noted that typically, only 2% of the database will qualify as buy candidates using these screening applications. Also, when the Market Edge "Market Posture" is bearish, there will not be any selections since the M part of the formula requires a favorable market environment. In order to qualify as a CANSLIM stock the company needs to have the following characteristics: • C=Current Earnings: Quarterly earnings per share are up 25% or more. • A=Annual Earnings: Five year average compounded earnings growth rate is greater that 24%. • N=New Highs: The stock is within 15% of making a new 52-week high and is breaking out of a period of consolodation. • S=Shares Outstanding: The number of shares outstanding is less than 50 million shares and there has been a recent increase in trading volume. • L=Leading Stocks: The company is a market leader reflected by a Relative Strength Value (RSV) of 80 or higher.A RSV of 80 means that the stock outperformed 80% of all other stocks in the data base during the past year. • I=Institutional Ownership: Institutional sponsorship should be minimal but there should be at least one major institution with a sizeable position in the stock. • M=Market Conditions: The Market Edge "Market Posture" should be Bullish.During periods when the posture is bearish, there will not be any selections.
by Saintl
S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | Exp Qtr EPS Rs. | EPS Qtr Rs. | Avg PAT 5Yrs Rs.Cr. |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
101. | Laurus Labs | 494.95 | 204.47 | 26685.69 | 0.16 | 19.95 | -46.31 | 1223.70 | -0.06 | 6.60 | 0.50 | 0.37 | 604.06 |
102. | A B Real Estate | 2709.65 | 193.83 | 30265.62 | 0.18 | 2.82 | 217.42 | 1127.56 | 30.67 | 8.31 | 10.19 | 0.23 | 145.48 |
103. | Orient Cement | 339.40 | 45.68 | 6953.25 | 0.66 | 2.32 | -90.58 | 544.03 | -24.50 | 16.13 | 2.65 | 0.11 | 171.99 |
104. | Jash Engineering | 476.30 | 42.44 | 2979.86 | 0.30 | 0.08 | 102.37 | 114.55 | 78.37 | 25.11 | 2.47 | 0.08 | 40.25 |
105. | Biocon | 348.70 | 29.01 | 41864.92 | 0.14 | 27.10 | -85.63 | 3590.40 | 3.70 | 5.96 | 1.92 | -0.13 | 755.39 |
106. | Nuvoco Vistas | 344.40 | 250.77 | 12300.46 | 0.00 | -85.17 | -5666.67 | 2268.58 | -11.83 | 5.42 | 0.39 | -2.38 | 163.76 |
107. | Astrazeneca Phar | 7256.45 | 138.47 | 18141.13 | 0.33 | -11.79 | -34.98 | 387.52 | 31.15 | 31.13 | 19.37 | -4.72 | 99.72 |
108. | S H Kelkar & Co. | 297.45 | 36.40 | 4117.33 | 0.25 | -86.82 | -35.83 | 470.31 | 11.30 | 12.46 | 3.60 | -6.25 | 107.62 |
109. | Chalet Hotels | 885.85 | 257.02 | 19333.32 | 0.00 | -138.51 | -480.15 | 377.05 | 19.87 | 10.06 | 5.21 | -6.35 | 64.74 |
110. | Monte Carlo Fas. | 789.90 | 27.60 | 1637.63 | 2.53 | -13.27 | -14.50 | 126.00 | -9.20 | 10.63 | -0.10 | -6.40 | 87.60 |